lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
1,144 rows where filing_year = 2021 and issue_code = "PHA" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2591009 | STEPHANIE A. BURGESS INC 4680713d-bdad-486c-9d8c-1bde890eb590 | 1T | STEPHANIE A. BURGESS INC | 401105595 | VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES | 2021 | first_quarter | PHA | Issues related to prescription drug importation, fentanyl scheduling, increased funding for law enforcement to combat fentanyl trafficking, combating pill presses, enhanced penalties for wholesale prescription drug trafficking, counterfeit prevention efforts, enforcement against counterfeits, opioid prevention and recovery, WHOIS & Lock and Suspend, Byrne JAG funding. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2021-01-20T13:08:09.747000-05:00 | ||
| 2591408 | LUNGREN LOPINA LLC 868e1e06-02bf-4f9e-a494-e2810effa5f1 | Q1 | LUNGREN LOPINA LLC | 401103314 | AMPAC FINE CHEMICALS | 2021 | first_quarter | PHA | Fair treatment for US based pharmaceutical ingredients | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-04-01T11:46:28.043000-04:00 | |
| 2591424 | PANNONE LOPES DEVEREAUX & O'GARA LLC 68a232a4-7f34-4412-b907-e8f339114120 | Q1 | PANNONE LOPES DEVEREAUX & O'GARA LLC | 401105501 | AMGEN | 2021 | first_quarter | PHA | Prescription drug pricing. | 9000 | 0 | 0 | 2021-04-01T12:42:33.730000-04:00 | ||
| 2592563 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION c9913018-55e0-480d-8a76-b91f74848f9d | Q1 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION | 401103605 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION | 2021 | first_quarter | PHA | COVID-19 vaccine & therapeutic production, and pandemic protection. Pharmaceutical supply chain and domestic manufacturing | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-07T13:22:30.830000-04:00 | |
| 2592654 | STONINGTON GLOBAL 7b2241cd-9c84-44ba-995a-7a8ed296f758 | Q1 | STONINGTON GLOBAL | 401105189 | SORRENTO THERAPEUTICS, INC. | 2021 | first_quarter | PHA | Regulatory approvals and funding for pharmaceutical products and devices | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 150000 | 0 | 0 | 2021-04-07T19:25:57.163000-04:00 | |
| 2593192 | PUBLIC CITIZEN 590cbc34-6857-42cd-917d-6dced46bda70 | Q1 | PUBLIC CITIZEN | 32362 | PUBLIC CITIZEN | 2021 | first_quarter | PHA | Covid-19 medicine pricing and access, drug price negotiation, biologics exclusivity, NIST legislative package, Pandemic treatment access and affordability act, Pandemic emergency Manufacturing Act, Medicare and Medicaid prescription drug rebates, We PAID act, Empowering Medicare seniors to Negotiate drug Pricing act, global COVID 19 vaccine access, Stop Stalling act, drug price spike excise act, repealing direct to consumer advertisement tax, Stop Price Gouging Act, Preserving access to affordable generics, TRACK act, drug R&D cost transparency, using executive authority to increase vaccine production. | Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Securities & Exchange Commission (SEC),SENATE,White House Office | 90000 | 0 | 0 | 2021-04-12T08:00:37.127000-04:00 | |
| 2593277 | POLSINELLI PC 208ea6f7-5298-4ccf-8e1e-dfcd3e91e176 | Q1 | POLSINELLI PC | 314911 | TEVA PHARMACEUTICALS USA, INC. | 2021 | first_quarter | PHA | H.R.1319, American Rescue Plan Act Issues related to pricing, reimbursement, and manufacturing of pharmaceutical products Review of Administration telehealth policies | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-04-12T10:43:48.120000-04:00 | |
| 2593585 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION db53ffda-1bcd-49c1-b6ef-37fcc1b3c9bf | Q1 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 29403 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2021 | first_quarter | PHA | OTC switch process -- no bill number | Commerce, Dept of (DOC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of | 111000 | 0 | 0 | 2021-04-12T16:32:21.017000-04:00 | |
| 2593679 | PENN AVENUE PARTNERS 8475240c-235b-44ea-b1d8-2e1082e148d1 | Q1 | PENN AVENUE PARTNERS | 400918672 | ALKERMES, INC. | 2021 | first_quarter | PHA | Regulatory and legislative issues impacting Alkermes. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-12T18:08:27.890000-04:00 | |
| 2594099 | AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 99423dd9-ec02-4faf-9401-9838f271af82 | 1T | AMERICAN SOCIETY OF CONSULTANT PHARMACISTS | 3446 | AMERICAN SOCIETY OF CONSULTANT PHARMACISTS | 2021 | first_quarter | PHA | american rescue plan, S333(nursing home protection act) S784 | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 1 | 2021-04-13T12:03:54.090000-04:00 | |
| 2594343 | MCDERMOTT+ LLC ca002339-ad26-4f9c-9d49-5c33678a7060 | Q1 | MCDERMOTT+ LLC | 401103287 | ALLIANCE FOR RURAL HOSPITAL ACCESS | 2021 | first_quarter | PHA | Amendments to Section 340B of the Public Health Service Act regarding eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-13T15:04:08.467000-04:00 | |
| 2594426 | TODD STRATEGY GROUP 73f46ee9-48c3-45e0-b017-3dcdd86228f3 | Q1 | TODD STRATEGY GROUP | 401103321 | ALKERMES, INC. | 2021 | first_quarter | PHA | Prescription drug pricing. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-13T15:40:28.267000-04:00 | |
| 2594433 | TODD STRATEGY GROUP 133ce123-779c-4521-9bf3-757a9ecce9ef | Q1 | TODD STRATEGY GROUP | 401103321 | ALKERMES, INC. | 2021 | first_quarter | PHA | Prescription drug pricing. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-13T15:41:31.293000-04:00 | |
| 2594496 | TODD STRATEGY GROUP ce66acb3-a22f-44dd-af5e-2e576e4272db | Q1 | TODD STRATEGY GROUP | 401103321 | BIOTECHNOLOGY INNOVATION ORGANIZATION | 2021 | first_quarter | PHA | Drug pricing and access. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 60000 | 0 | 0 | 2021-04-13T16:28:35.707000-04:00 | |
| 2594498 | TODD STRATEGY GROUP 0d84fe59-83fc-44dc-b9a8-6d47866c8c2b | Q1 | TODD STRATEGY GROUP | 401103321 | CAREDX, INC. | 2021 | first_quarter | PHA | Immunosuppressive drug coverage implementation. S.3404: VALID Act of 2020. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 40000 | 0 | 0 | 2021-04-13T16:31:37.003000-04:00 | |
| 2594507 | TODD STRATEGY GROUP ddd69a44-58a5-482c-b533-c868395f6339 | Q1 | TODD STRATEGY GROUP | 401103321 | EMD SERONO INC. | 2021 | first_quarter | PHA | Drug pricing policy. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-13T16:34:42.833000-04:00 | |
| 2594528 | TODD STRATEGY GROUP 68340f09-da59-405c-9c99-a292bc9b66d3 | Q1 | TODD STRATEGY GROUP | 401103321 | GENENTECH, INC. | 2021 | first_quarter | PHA | Prescription drug payment reform. Supply chain. Strategic National Stockpile. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-04-13T16:46:58.967000-04:00 | |
| 2594555 | TODD STRATEGY GROUP c9b1aa30-084c-4840-a0ff-c7ed7a1dc600 | Q1 | TODD STRATEGY GROUP | 401103321 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2021 | first_quarter | PHA | Drug Pricing and Access. Pharmaceutical Supply Chain. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-04-13T17:07:19.603000-04:00 | |
| 2594566 | TODD STRATEGY GROUP 1a3dd2ad-ae58-42f4-b1cc-7c3891554d5e | Q1 | TODD STRATEGY GROUP | 401103321 | US WORLDMEDS, LLC | 2021 | first_quarter | PHA | Opioid Use Disorder Treatment Policy. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2021-04-13T17:11:27.133000-04:00 | |
| 2594585 | INDEPENDENT PHARMACY COOPERATIVE 891e6b8e-a22f-4e52-8c1a-147a0be717eb | Q1 | INDEPENDENT PHARMACY COOPERATIVE | 313098 | INDEPENDENT PHARMACY COOPERATIVE | 2021 | first_quarter | PHA | Support regulations/laws that would eliminate pharmacy DIR. IPC supports Pharmacists as providers under Medicare Part B IPC supports Pharmacists as Immunizers IPC supports 340B Program and contract pharmacies IPC supports Federal Retail Pharmacy COVID-19 Vaccination Program expansion. | Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 30000 | 0 | 0 | 2021-04-13T17:30:36.723000-04:00 | |
| 2594633 | PENN AVENUE PARTNERS 8010d9f4-1e6e-4e67-bd1e-0b7d9d35b0b3 | Q1 | PENN AVENUE PARTNERS | 400918672 | UNITEDHEALTH GROUP, INC. | 2021 | first_quarter | PHA | Pharmacy benefit related issues. | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 90000 | 0 | 0 | 2021-04-13T18:15:51.647000-04:00 | |
| 2594716 | OFF HILL STRATEGIES L.L.C. 73a0b68b-ad92-4b4a-bd28-d062feaca632 | Q1 | OFF HILL STRATEGIES L.L.C. | 401103327 | FINANCIAL OVERSIGHT AND MANAGEMENT BOARD FOR PUERTO RICO | 2021 | first_quarter | PHA | Monitored pharmaceutical supply chain legislation/ policies | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 60000 | 0 | 0 | 2021-04-13T21:17:16.137000-04:00 | |
| 2594801 | PARAGON BIOSCIENCES, LLC 055375df-8df2-4ed0-af67-0c54affedfbf | Q1 | PARAGON BIOSCIENCES, LLC | 401105338 | PARAGON BIOSCIENCES, LLC | 2021 | first_quarter | PHA | Issues related to public and private investment in biosciences and R&D | 0 | 0 | 2021-04-14T09:33:45.827000-04:00 | |||
| 2595207 | AARP 694534f9-e7ee-4036-93f2-3c561b98c3af | Q1 | AARP | 1694 | AARP | 2021 | first_quarter | PHA | Public L.117-2, American Rescue Plan Act of 2021 No bill number - Discussed vaccine coverage, development, approval, funding, distribution and prioritization No bill number - Discussed vaccine coverage No bill number - Discussed drug pricing reforms, including price negotiation, out-of-pocket cap, and inflation-based rebates | Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Consumer Financial Protection Bureau (CFPB),Corporation for Natl & Community Service,Defense, Dept of (DOD),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Indian Health Service,Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Institutes of Health (NIH),Natl Transportation Safety Board (NTSB),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of the Comptroller of the Currency (OCC),Pension Benefit Guaranty Corporation (PBGC),Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,Veterans Affairs, Dept of (VA),White House Office | 2840000 | 0 | 0 | 2021-04-14T13:14:18.377000-04:00 | |
| 2595496 | CRISPR THERAPEUTICS, INC. dc9ffc56-286e-4c26-9958-dc369654352b | Q1 | CRISPR THERAPEUTICS, INC. | 401105184 | CRISPR THERAPEUTICS, INC. | 2021 | first_quarter | PHA | Coverage & reimbursement for Cell and Gene Therapies | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2021-04-14T16:19:10.123000-04:00 | |
| 2595660 | ACG ADVOCACY 599487bc-9c8f-41e7-9a42-b0c83c3cd6b4 | Q1 | ACG ADVOCACY | 2057 | WALGREEN CO. | 2021 | first_quarter | PHA | Drug Pricing Policy Issues. Data privacy and DIR fee reform. Public Health Crisis. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-14T17:34:04.727000-04:00 | |
| 2595707 | RED+BLUE STRATEGIES 2b66b162-e094-4996-910a-f293c218d45a | Q1 | RED+BLUE STRATEGIES | 400693064 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | 2021 | first_quarter | PHA | PL 177-2 - The American Rescue Plan Act - Issues related to increasing access to health care coverage, including access to prescription drugs, for Americans with both public and private insurance. Issues related to Trump-era rules and regulations regarding Medicare rebate policies and PBM transparency. | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2021-04-14T18:36:18.757000-04:00 | |
| 2595709 | RED+BLUE STRATEGIES cbae9e21-927d-4c15-8899-cb8858e838b0 | Q1 | RED+BLUE STRATEGIES | 400693064 | PEW CHARITABLE TRUSTS | 2021 | first_quarter | PHA | PL 177-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, the need for a more robust pipeline for antibiotics to protect the nation, a more coherent HIT system to ensure robust public data and other related public health issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. Issues related to ensuring clear information regarding the safety of supplements. Issues related to dealing with antimicrobial resistance among the US population. | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 60000 | 0 | 0 | 2021-04-14T19:23:20.097000-04:00 | |
| 2595721 | RED+BLUE STRATEGIES ef115b3f-2775-46fa-81e8-99303d98485c | Q1 | RED+BLUE STRATEGIES | 400693064 | COHERUS BIOSCIENCES | 2021 | first_quarter | PHA | S. 164 - Biosimilars Education Act of 2021 - A bill to raise awareness of the efficacy and promise of biosimilars in the American health care system. Issues and policies that incent companies to increase their US footprint and adopt Made in America business practices. Policies to help grow the biosimilars marketplace in the United States. Policies focused on improving cancer care through access to affordable treatments. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-04-14T20:13:24.497000-04:00 | |
| 2595780 | REPUBLIC CONSULTING, LLC 58fedfd2-cdc3-47be-b7cf-2e2b95b60a1f | Q1 | REPUBLIC CONSULTING, LLC | 401016871 | IQVIA | 2021 | first_quarter | PHA | Monitored Health Data Policy. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-04-15T08:39:42.810000-04:00 | |
| 2596177 | RUBICON ADVISORS, LLC 39277903-a314-4c12-97bf-a6b91c587cbd | Q1 | RUBICON ADVISORS, LLC | 315091 | CONSCIOUS DISCIPLINE | 2021 | first_quarter | PHA | Medicare | HOUSE OF REPRESENTATIVES,SENATE | 67500 | 0 | 0 | 2021-04-15T12:33:29.383000-04:00 | |
| 2596186 | RUBICON ADVISORS, LLC 05b057f0-c693-49bc-a7be-93bf20f1a6e9 | Q1 | RUBICON ADVISORS, LLC | 315091 | DYNAVAX TECHNOLOGIES | 2021 | first_quarter | PHA | Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA) | HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2021-04-15T12:37:32.237000-04:00 | |
| 2596191 | RUBICON ADVISORS, LLC c53959c7-8f0c-49aa-9821-f8baeed37591 | Q1 | RUBICON ADVISORS, LLC | 315091 | DR. REDDY'S LABORATORIES, LTD | 2021 | first_quarter | PHA | Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues | Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 60000 | 0 | 0 | 2021-04-15T12:40:34.080000-04:00 | |
| 2596193 | RUBICON ADVISORS, LLC 23ed0ddd-e69e-45ab-8981-fe10bbaa7abf | Q1 | RUBICON ADVISORS, LLC | 315091 | LANNETT COMPANY, INC | 2021 | first_quarter | PHA | Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 50000 | 0 | 0 | 2021-04-15T12:42:35.257000-04:00 | |
| 2596199 | RUBICON ADVISORS, LLC e21c6534-833c-407d-84ad-9603aac144e3 | Q1 | RUBICON ADVISORS, LLC | 315091 | AVET PHARMACEUTICALS | 2021 | first_quarter | PHA | GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES | 30000 | 0 | 0 | 2021-04-15T12:44:37.577000-04:00 | |
| 2596206 | RUBICON ADVISORS, LLC d9d0aae7-eddd-42f1-88be-77bea67ef473 | Q1 | RUBICON ADVISORS, LLC | 315091 | ASCENDIS PHARMA, INC. | 2021 | first_quarter | PHA | Food and Drug Administration, Orphan Drugs | Food & Drug Administration (FDA) | 60000 | 0 | 0 | 2021-04-15T12:52:40.387000-04:00 | |
| 2596220 | KOUNTOUPES DENHAM CARR & REID, LLC c34b1284-bf9a-49df-9282-aeb1ced07f95 | Q1 | KOUNTOUPES DENHAM CARR & REID, LLC | 320918 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2021 | first_quarter | PHA | General issues related to over the counter pharmaceuticals and pharmaceutical supply chain. Implementation of the Over the Counter Monograph provisions included in PL 116-136, Coronavirus Aid, Relief and Economic Security Act. Issues related to supplements. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-15T13:00:43.103000-04:00 | |
| 2596229 | RUBICON ADVISORS, LLC 36819046-18f6-4d15-a565-f1b753316192 | Q1 | RUBICON ADVISORS, LLC | 315091 | HYPOPARATHYROIDISM ASSOCIATION | 2021 | first_quarter | PHA | Rare disease issues Orphan drugs | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS) | 0 | 0 | 2021-04-15T13:13:47.003000-04:00 | ||
| 2596325 | KOUNTOUPES DENHAM CARR & REID, LLC 0683667d-8c1b-4b48-bf61-8f2dff90561e | Q1 | KOUNTOUPES DENHAM CARR & REID, LLC | 320918 | GLENMARK PHARMACEUTICALS, INC., USA | 2021 | first_quarter | PHA | Issues related to H.R. 1319, the American Rescue Plan. Issues related to affordability, essential medicine manufacturing and supply chain, and pricing of pharmaceuticals. General issues related to the generic drug industry. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-15T14:00:18.890000-04:00 | |
| 2596389 | AMERICAN COLLEGE OF CLINICAL PHARMACY 6471f83a-97bc-4294-b1b9-1a5a742d00ca | Q1 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2021 | first_quarter | PHA | Coverage for direct patient care services of qualified clinical pharmacists under Medicare and other public health programs. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 144981 | 0 | 0 | 2021-04-15T14:34:43.143000-04:00 | |
| 2596671 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 48c32028-ee05-482f-8820-3818f45f78e1 | Q1 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 312496 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 2021 | first_quarter | PHA | 340B | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 30890 | 0 | 0 | 2021-04-15T17:01:11.273000-04:00 | |
| 2596713 | TODD STRATEGY GROUP b2021dbe-509a-4bdf-85a2-6ae15d211807 | Q1 | TODD STRATEGY GROUP | 401103321 | BAYER CORPORATION | 2021 | first_quarter | PHA | Drug pricing. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-15T17:37:23.930000-04:00 | |
| 2596779 | BROYDRICK & ASSOCIATES 41e2423a-fc21-4068-b974-eb130f4f3bc7 | Q1 | BROYDRICK & ASSOCIATES | 7268 | EXELA PHARMA SCIENCES | 2021 | first_quarter | PHA | Drug shortages and FDA approval, USTR acceptance. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2021-04-15T18:43:47.097000-04:00 | ||
| 2596794 | BROYDRICK & ASSOCIATES dc7c05b4-3a58-4f49-a6e5-b769197bdaec | Q1 | BROYDRICK & ASSOCIATES | 7268 | TONIX PHARMACEUTICALS | 2021 | first_quarter | PHA | Funding new drug for PTSD and COVID 19. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2021-04-15T18:57:53.827000-04:00 | |
| 2597157 | ASSOCIATION FOR ACCESSIBLE MEDICINES 909fc0f9-87cd-4873-8016-70be99794c19 | Q1 | ASSOCIATION FOR ACCESSIBLE MEDICINES | 16032 | ASSOCIATION FOR ACCESSIBLE MEDICINES | 2021 | first_quarter | PHA | Prescription Drug Costs. Drug Pricing. Pharmaceutical Exclusivity. 180-Day Exclusivity. Forfeiture of 180-Day Exclusivity. 12-Year Exclusivity. Contract Genericization. 30-Month Stays. Labeling of Generic Drugs and Biosimilars. Modern Labeling. Generic carveouts patent protected information in drug labels, including issues related to GSK v. Teva. Orange Book. Drug Shortages. S.917: Short on Competition Act. Stockpile of Generic Drugs. Generic Drug User Fee Amendments (GDUFA). GDUFA III Negotiations. Biosimilar User Fee Act (BsUFA). BsUFA III Negotiations. Biosimilars Naming. Biosimilars Insulin. Pass-through Payments for Biosimilars. Cost Sharing for Biosimilars. Implementation of Food and Drug Administration Reauthorization Act (FDARA). FDA Inspections. Buy American Proposals. Issues Related to COVID-19. Secretary Azar Importation Plan. | Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,U.S. Trade Representative (USTR) | 880000 | 0 | 0 | 2021-04-16T10:45:32.463000-04:00 | |
| 2597415 | 4C COMMUNICATIONS, INC. 9a6e19a7-28cf-4f45-b74a-7aeca10daf3d | Q1 | 4C COMMUNICATIONS, INC. | 323717 | HEALTHCARE LEADERSHIP COUNCIL | 2021 | first_quarter | PHA | The Treat Act | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2021-04-16T12:03:35.603000-04:00 | ||
| 2597556 | MARSHALL & POPP, LLC 793b15c0-d92b-435b-a479-a19d8de96d22 | Q1 | MARSHALL & POPP, LLC | 401105121 | AMGEN USA INC. | 2021 | first_quarter | PHA | Issues related to prescription drug value, supply chains, 340B, and the COVID-19 pandemic, including: *S.Con.Res. 5, fiscal year 2021 budget resolution. *H.R.1319: American Rescue Plan Act of 2021. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-04-16T12:21:06.410000-04:00 | |
| 2597626 | MARSHALL & POPP, LLC 225badc0-c273-4915-8109-09282cef5b3e | Q1 | MARSHALL & POPP, LLC | 401105121 | GENENTECH, INC. | 2021 | first_quarter | PHA | Issues related to prescription drug value, supply chains, 340B, and the COVID-19 pandemic, including: *S.Con.Res. 5, fiscal year 2021 budget resolution. *H.R.1319: American Rescue Plan Act of 2021. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-04-16T12:34:21.377000-04:00 | |
| 2597701 | COVINGTON & BURLING LLP 1a7fc91c-e94c-4a23-95da-396923f74a50 | Q1 | COVINGTON & BURLING LLP | 11195 | 1776 PHARMACEUTICALS LLC | 2021 | first_quarter | PHA | Re-shoring production of essential medicine | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-04-16T12:52:39.027000-04:00 | |
| 2597801 | MARSHALL & POPP, LLC 6d4d623b-b4d9-4da9-9feb-a24fb29f3119 | Q1 | MARSHALL & POPP, LLC | 401105121 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2021 | first_quarter | PHA | Issues related to prescription drug value, supply chains, 340B, and the COVID-19 pandemic, including: *S.Con.Res. 5, fiscal year 2021 budget resolution. *H.R.1319: American Rescue Plan Act of 2021. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-04-16T13:27:04.867000-04:00 | |
| 2597815 | MARSHALL & POPP, LLC d111e75f-230f-431c-b266-4aede4ec97aa | Q1 | MARSHALL & POPP, LLC | 401105121 | SANOFI U.S. SERVICES, INC. | 2021 | first_quarter | PHA | Issues related to prescription drug value, supply chains, 340B, and the COVID-19 pandemic, including: *S.Con.Res. 5, fiscal year 2021 budget resolution. *H.R.1319: American Rescue Plan Act of 2021. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-04-16T13:30:08.670000-04:00 | |
| 2597865 | LINCOLN PARK GROUP L.L.C. a80ddce7-0f63-434f-905d-99774a2418ca | Q1 | LINCOLN PARK GROUP L.L.C. | 401104374 | CANADIAN INTERNATIONAL PHARMACY ASSOCIATION | 2021 | first_quarter | PHA | Support for S. 920/H.R. 2181 - A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals and S. 259/H.R. 832 - Safe and Affordable Drugs from Canada Act; issues related to personal drug importation. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-04-16T13:44:24.673000-04:00 | |
| 2597881 | SUMMIT PUBLIC AFFAIRS fd4a8886-3e6e-4359-bffd-fa337a0f7928 | Q1 | SUMMIT PUBLIC AFFAIRS | 401105467 | VANDA PHARMACEUTICALS INC. | 2021 | first_quarter | PHA | Issues affecting the pharmaceutical industry, including the prescription drug approval process, animal testing, and gastroparesis issues. COVID-19 clinical trials. H.R. 1319, American Rescue Plan Act of 2021. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-04-16T13:47:28.867000-04:00 | |
| 2598015 | HOGAN LOVELLS US LLP de129df1-52e8-4a53-bdb0-6a8b37171f16 | Q1 | HOGAN LOVELLS US LLP | 18422 | ALVOGEN, PHARMA US, INC. | 2021 | first_quarter | PHA | Issues related to COVID-19 | HOUSE OF REPRESENTATIVES,SENATE | 410000 | 0 | 0 | 2021-04-16T14:20:07.040000-04:00 | |
| 2598225 | FAEGRE DRINKER BIDDLE & REATH LLP 27f32965-aec6-49ad-a10a-ea51172baac9 | Q1 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | NATIONAL ASSOCIATION OF BOARDS OF PHARMACY | 2021 | first_quarter | PHA | Medication safety, pharmacy regulation, and the opioid epidemic; prescription drug monitoring programs; COVID-19 response; H.R. 2482, S. 2074 - Mainstreaming Addiction Treatment Act; opposing prescription drug importation. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-16T15:15:09.617000-04:00 | |
| 2598227 | FAEGRE DRINKER BIDDLE & REATH LLP 6b7b95f1-93e0-42b4-b790-5891b884acf3 | Q1 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) | 2021 | first_quarter | PHA | Illicit prescription drug sales online; rouge internet drug sellers; dangers of counterfeit medicines; risks of drug importation on patient safety; domain name system accountability regarding COVID-19 frauds; WHOIS; Communications Decency Act, Section 230 reform; STOP Act implementation. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 70000 | 0 | 0 | 2021-04-16T15:16:10.457000-04:00 | |
| 2598280 | BUCHANAN INGERSOLL & ROONEY PC 33901d14-3e95-465d-a483-10b6d44c3d57 | Q1 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | GENERIC ANIMAL DRUG ALLIANCE | 2021 | first_quarter | PHA | Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2021-04-16T15:31:24.800000-04:00 | |
| 2598297 | 340B HEALTH 0ecd5a64-dafe-4d76-93cf-aeeaab5cb39e | Q1 | 340B HEALTH | 316434 | 340B HEALTH | 2021 | first_quarter | PHA | The 340B Drug Pricing Program; S.773 - A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; H.R. 853: Closing Loopholes for Orphan Drugs Act; H.R.1319 - American Rescue Plan Act of 2021. | Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 292698 | 0 | 0 | 2021-04-16T15:36:30.673000-04:00 | |
| 2598311 | BLUECROSS BLUESHIELD OF TENNESSEE f502cd90-ea26-424c-bd91-997ae3000703 | Q1 | BLUECROSS BLUESHIELD OF TENNESSEE | 6440 | BLUECROSS BLUESHIELD OF TENNESSEE | 2021 | first_quarter | PHA | COVID-19 Testing; Vaccine Strategy and Treatment | HOUSE OF REPRESENTATIVES,SENATE | 351297 | 0 | 0 | 2021-04-16T15:39:35.877000-04:00 | |
| 2598440 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS fe311a0f-ea2d-4613-b919-45fc27ad65b3 | Q1 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 3457 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 2021 | first_quarter | PHA | Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Conversation with DEA regulation on Medication-Assisted Treatment and drug shortages. Discussed COVID-19 response recommendations with House and Senate Offices, HHS and its subagencies, and DEA. Contact HHS, House and Senate Offices concerning rule enforcement of the 340B Drug Pricing Program. Contact FDA concerning the practice of White Bagging and Brown Bagging patient medications. | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 310000 | 0 | 0 | 2021-04-16T16:07:12.943000-04:00 | |
| 2598588 | MASSACHUSETTS MEDICAL SOCIETY 223f495c-19fb-4af8-8015-8c1fe970734a | Q1 | MASSACHUSETTS MEDICAL SOCIETY | 23975 | MASSACHUSETTS MEDICAL SOCIETY | 2021 | first_quarter | PHA | Issues related to prescription drug prices - no specific bill Issues related to vaccines - no specific bill | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-16T16:49:47.173000-04:00 | |
| 2598796 | BLUECROSS BLUESHIELD OF TENNESSEE fbdead67-adcb-4d3e-9980-1e054b0b2330 | 1A | BLUECROSS BLUESHIELD OF TENNESSEE | 6440 | BLUECROSS BLUESHIELD OF TENNESSEE | 2021 | first_quarter | PHA | COVID-19 Testing; Vaccine Strategy and Treatment | HOUSE OF REPRESENTATIVES,SENATE | 350000 | 0 | 0 | 2021-04-16T17:59:32.857000-04:00 | |
| 2599018 | FORBES-TATE 25f1bd84-095b-49e4-8725-cd484aa89f12 | Q1 | FORBES-TATE | 400976792 | CALIFORNIA LIFE SCIENCES ASSOCIATION | 2021 | first_quarter | PHA | Issues related to the life sciences industry; Issues related to drug pricing and international reference pricing. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-17T10:29:10.167000-04:00 | |
| 2599084 | FORBES-TATE 67276655-f868-4b30-9392-33391cddc53c | Q1 | FORBES-TATE | 400976792 | MERCK | 2021 | first_quarter | PHA | Issues related to prescription drug pricing, vaccines, animal health, and maternal health. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-17T11:12:47.640000-04:00 | |
| 2599142 | FORBES-TATE c45a85a5-7815-4ba8-85b4-8f86ad517cf9 | Q1 | FORBES-TATE | 400976792 | PHRMA | 2021 | first_quarter | PHA | Issues pertaining to prescription drug pricing. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-04-17T11:50:36.587000-04:00 | |
| 2599499 | CAPITOL COUNSEL LLC 2cd7ef58-319c-451b-8926-f14c507f2530 | Q1 | CAPITOL COUNSEL LLC | 313715 | EMD SERONO, INC. | 2021 | first_quarter | PHA | Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2021-04-17T16:34:23.210000-04:00 | |
| 2599516 | CAPITOL COUNSEL LLC 0f806121-a039-4450-bcfb-bda78c063649 | Q1 | CAPITOL COUNSEL LLC | 313715 | VERTEX PHARMACEUTICALS INCORPORATED | 2021 | first_quarter | PHA | Monitoring and advocacy on matters related to the pharmaceutical industry. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2021-04-17T16:47:26.777000-04:00 | |
| 2599661 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 22d83402-0f3c-4a0b-926e-eba44effe71e | Q1 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 35968 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021 | first_quarter | PHA | Compounding, preparation, packaging and dispensing of radiopharmaceuticals | Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),Office of Science & Technology Policy (OSTP),SENATE | 48000 | 0 | 0 | 2021-04-18T08:52:14.947000-04:00 | |
| 2599793 | TARPLIN, DOWNS & YOUNG, LLC 91ea6662-58e6-4931-8fa9-25f6d1ae1d06 | Q1 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | ASTRAZENECA | 2021 | first_quarter | PHA | Drug coverage & reimbursement vaccination no specific bills, Import Safety, drug development policy, drug shortages, supply chain integrity, Innovation, reimportation, transparency, 340B, pay for delay | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-04-18T13:30:57.280000-04:00 | |
| 2599824 | KOUNTOUPES DENHAM CARR & REID, LLC fcee1c35-ff3a-48d0-9d46-d2f208ec2d2e | Q1 | KOUNTOUPES DENHAM CARR & REID, LLC | 320918 | ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY - GENERIC PHARMACEUTICAL ASSN) | 2021 | first_quarter | PHA | Issues related to generic pharmaceuticals and biosimilars, including H.R. 928, the BLOCKING Act of 2019. Reimbursement rate for biosimilars. Issues related to the implementation of H.R. 133, Consolidated Appropriations Act for Fiscal Year 2021. Issues related to H.R. 1319, The American Rescue Plan. Issues related to the pharmaceutical supply chain and domestic manufacturing. Issues related to H.R. 6179, Increasing Access to Biosimilars Act of 2020, H.R. 4597, the ACCESS Act, and H.R. 4455, the Biosim Act. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-04-18T14:12:06.457000-04:00 | |
| 2600017 | TARPLIN, DOWNS & YOUNG, LLC 032f8b9b-f73f-4c9f-87a1-23e8e65dc8ca | Q1 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2021 | first_quarter | PHA | H.R. 1319, American Rescue Plan of 2021 no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, patent settlements, break through therapies, Innovation, transparency no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee reauthorization, Innovation | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 80000 | 0 | 0 | 2021-04-18T17:59:55.807000-04:00 | |
| 2600242 | VAN SCOYOC ASSOCIATES a0fe9715-3350-46ad-a625-b65c203df59e | Q1 | VAN SCOYOC ASSOCIATES | 39837 | ZEBRA TECHNOLOGIES CORP. | 2021 | first_quarter | PHA | Temperature monitoring technology for COVID-19 vaccines, generally Public Law 117-7, American Rescue Plan Act of 2021, Temperature monitoring technology | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2021-04-19T06:21:57.887000-04:00 | |
| 2600780 | ELI LILLY AND COMPANY 6a80140a-417f-423f-a5cd-0469b2babcad | Q1 | ELI LILLY AND COMPANY | 13392 | ELI LILLY AND COMPANY | 2021 | first_quarter | PHA | Hospital discounts; 340B program | Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR) | 1840000 | 0 | 0 | 2021-04-19T09:47:49.270000-04:00 | |
| 2601148 | UNIVERSITY OF IOWA 6a5bed25-7edc-4377-b284-bc2514dda0d9 | Q1 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2021 | first_quarter | PHA | N/A | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 80000 | 0 | 0 | 2021-04-19T10:34:06.737000-04:00 | |
| 2601523 | GOVERNMENT COUNSEL, LLC 42b7162e-1b5c-4b3e-9666-4575d657af20 | Q1 | GOVERNMENT COUNSEL, LLC | 401105070 | HEALTHCARE DISTRIBUTION ALLIANCE | 2021 | first_quarter | PHA | H.R. 768-Block, Report, And Suspend Suspicious Shipments Act of 2021; DEA Proposed Rule on Suspicious Orders of Controlled Substances [85 Fed. Reg. 69282 (November 2, 2020)] Docket No. DEA-437; General issues relating to implementation of Public Law 113-54 (DSCSA). | HOUSE OF REPRESENTATIVES | 60000 | 0 | 0 | 2021-04-19T11:03:31.833000-04:00 | |
| 2601600 | HANCE SCARBOROUGH 13322c89-3761-467b-8c41-7ecfd0dc2cab | Q1 | HANCE SCARBOROUGH | 17443 | PHRMA | 2021 | first_quarter | PHA | Patent reform regarding pharmaceutical research & products. | SENATE | 30000 | 0 | 0 | 2021-04-19T11:09:54.877000-04:00 | |
| 2602328 | ELI LILLY AND COMPANY 42caff2d-ddac-4d83-9061-bc8f0ff3af25 | 1A | ELI LILLY AND COMPANY | 13392 | ELI LILLY AND COMPANY | 2021 | first_quarter | PHA | Hospital discounts; 340B program | Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR) | 1840000 | 0 | 0 | 2021-04-19T12:08:02.790000-04:00 | |
| 2602619 | BAVARIAN NORDIC INC. 5a342a79-36e2-44cb-8a10-ff6a580fc84d | Q1 | BAVARIAN NORDIC INC. | 312257 | BAVARIAN NORDIC INC. | 2021 | first_quarter | PHA | Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; cancer; PAHPA; Labor-HHS-ED appropriations bills | HOUSE OF REPRESENTATIVES,SENATE | 130000 | 0 | 0 | 2021-04-19T12:32:07.477000-04:00 | |
| 2602885 | THERMO FISHER SCIENTIFIC INC. 8ad55cb6-b5ac-40aa-93f8-fcc7a2041fb7 | Q1 | THERMO FISHER SCIENTIFIC INC. | 323251 | THERMO FISHER SCIENTIFIC INC | 2021 | first_quarter | PHA | Worker training program. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Food & Drug Administration (FDA),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 1300000 | 0 | 0 | 2021-04-19T13:02:11.220000-04:00 | |
| 2603115 | NATIONAL RURAL HEALTH ASSOCATION c0186c1b-583d-477b-8fcc-c1440e8dd456 | Q1 | NATIONAL RURAL HEALTH ASSOCATION | 53048 | NATIONAL RURAL HEALTH ASSOCATION | 2021 | first_quarter | PHA | The 340B Program and drug pricing | Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE | 76501 | 0 | 0 | 2021-04-19T13:23:09.367000-04:00 | |
| 2603310 | TARPLIN, DOWNS & YOUNG, LLC b744236c-31ab-493b-8f9e-e553b790cbca | Q1 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) | 2021 | first_quarter | PHA | Opioid Abuse - General issues related to opioid abuse (implementation of Public Law 115-271) Issues related to ARCOS data and suspicious order record requirements and reporting (HR 768) Importation of Prescription Drugs (HR 832, HR 2181, S 259, S 920, Public Law 108-173) Implementation of Public Law 113-54 (DSCSA) | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-04-19T13:43:53.997000-04:00 | |
| 2603571 | HANCE SCARBOROUGH dc63d2d7-9fcd-4e6e-9f97-562c841e9565 | Q1 | HANCE SCARBOROUGH | 17443 | ALLIANCE FOR PHARMACY COMPOUNDING | 2021 | first_quarter | PHA | Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2022 Appropriations | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-04-19T14:13:01.597000-04:00 | |
| 2603864 | HANCE SCARBOROUGH 146e34f8-2d8c-47c0-9c7a-5e0cf7880680 | Q1 | HANCE SCARBOROUGH | 17443 | BOEHRINGER INGELHEIM USA CORPORATION | 2021 | first_quarter | PHA | Provide ongoing animal health policy monitoring, assessment, and research support. Telemedicine/telehealth legislation. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2021-04-19T14:36:24.553000-04:00 | |
| 2603998 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 16b62b4d-acb3-47d4-a30e-0302ecf7c059 | Q1 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | 28776 | HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) | 2021 | first_quarter | PHA | Opioid Abuse - General issues related to opioid abuse (implementation of Public Law 115-271) Issues related to ARCOS data and suspicious order record requirements and reporting Importation of Prescription Drugs (HR 832, HR 2181, S 259, S 920, Public Law 108-173) Implementation of Public Law 113-54 (DSCSA) Block, Report, and Suspend Suspicious Shipments Act of 2021 (HR 768) | Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 278719 | 0 | 0 | 2021-04-19T14:43:53.827000-04:00 | |
| 2604078 | BUCHANAN INGERSOLL & ROONEY PC 76ae5829-d1a0-4e6c-bb41-4a08bf881d0e | 1T | BUCHANAN INGERSOLL & ROONEY PC | 55291 | PHARMACEUTICAL ASSOCIATES, INC. | 2021 | first_quarter | PHA | Strategy development and implementation of company's federal government relations initiatives. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2021-04-19T14:50:16.577000-04:00 | |
| 2604277 | WAXMAN STRATEGIES 2944f5ad-0b3d-4be3-903f-ae72f9a2ef29 | Q1 | WAXMAN STRATEGIES | 401103693 | 340B HEALTH | 2021 | first_quarter | PHA | Issues affecting the 340B drug pricing program; Appropriations for 340B program. | HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2021-04-19T15:08:06.547000-04:00 | |
| 2604501 | M.J. SIMON & COMPANY, LLC 0a5e098f-5cd4-49e4-80e9-c39f4acb74c4 | Q1 | M.J. SIMON & COMPANY, LLC | 40026223 | NOBELPHARMA AMERICA | 2021 | first_quarter | PHA | FDA inspections | HOUSE OF REPRESENTATIVES,SENATE | 5000 | 0 | 0 | 2021-04-19T15:27:01.557000-04:00 | |
| 2604528 | WINNING STRATEGIES WASHINGTON 643af1d6-0730-484e-990c-1cdbda9fbfc6 | Q1 | WINNING STRATEGIES WASHINGTON | 50796 | KALEO | 2021 | first_quarter | PHA | Pharmaceutical drug development, including epinephrine for anaphylaxis; drug access and affordability issues | Federal Emergency Management Agency (FEMA),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-04-19T15:29:08.120000-04:00 | |
| 2604595 | BOCKORNY GROUP, INC. 8dda7526-a7a7-4642-8468-2dd9bd94edd9 | Q1 | BOCKORNY GROUP, INC. | 289773 | CVS HEALTH INC | 2021 | first_quarter | PHA | Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages H.R. 133 Consolidated Appropriations Act, 2021 | Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 80000 | 0 | 0 | 2021-04-19T15:34:22.953000-04:00 | |
| 2604874 | ARTEMIS POLICY GROUP LLC 3007b2f3-a7a7-4b40-9a8a-a05942519174 | Q1 | ARTEMIS POLICY GROUP LLC | 401105617 | AMERICAN SOCIETY OF HEMATOLOGY | 2021 | first_quarter | PHA | FDA policies related to research and approvals of treatments for hematological diseases | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2021-04-19T15:55:19.570000-04:00 | |
| 2604942 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) b32fcda3-af9a-432c-b213-52673bc01718 | Q1 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 400762305 | AMERISOURCEBERGEN CORPORATION | 2021 | first_quarter | PHA | Issues related to drug pricing and transparency, generally. Issues related to the importation of prescription medicines Issues related to the pharmaceutical supply chain and stockpiling Issues related to COVID vaccine distribution | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-04-19T15:58:34.120000-04:00 | |
| 2604945 | ARTEMIS POLICY GROUP LLC 2c5aa288-94f7-4cca-a6ce-47af877529e5 | Q1 | ARTEMIS POLICY GROUP LLC | 401105617 | THE HEMOPHILIA ALLIANCE | 2021 | first_quarter | PHA | Issues related to participation in the 340B Drug Discount Program | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 42000 | 0 | 0 | 2021-04-19T15:58:34.607000-04:00 | |
| 2605002 | ARTEMIS POLICY GROUP LLC af14d68b-14fd-4232-a1bb-5adade1829e7 | Q1 | ARTEMIS POLICY GROUP LLC | 401105617 | NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) | 2021 | first_quarter | PHA | Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Natl Institutes of Health (NIH),SENATE | 51000 | 0 | 0 | 2021-04-19T16:02:48.210000-04:00 | |
| 2605105 | MUSCULAR DYSTROPHY ASSOCIATION, INC. 06672678-0605-437c-852f-8bad538c1d8a | Q1 | MUSCULAR DYSTROPHY ASSOCIATION, INC. | 400348610 | MUSCULAR DYSTROPHY ASSOCIATION, INC. | 2021 | first_quarter | PHA | Advocated for provisions that enable ongoing access to necessary medications and treatments for neuromuscular disease patients throughout theCOVID-19 pandemic. Advocated for the reintroduction of the ACT for ALS, legislation that should accelerate development of treatments for individuals with ALS and other neuromuscular diseases. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT) | 100000 | 0 | 0 | 2021-04-19T16:10:09.200000-04:00 | |
| 2605299 | THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH f18992dd-f902-4265-b1c7-53a4176d2965 | Q1 | THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH | 401104060 | THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH | 2021 | first_quarter | PHA | General education around pharmaceuticals related to Parkinson's disease | Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 25000 | 0 | 0 | 2021-04-19T16:23:48.927000-04:00 | |
| 2605459 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES fe851c86-99df-4ddf-a9d3-f457b2853686 | Q1 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 26672 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 2021 | first_quarter | PHA | Interfaced with the White House, Operation Warp Speed; HHS Secretary and team, and CDC to drive COVID testing & vaccinations across the nation. | Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 195000 | 0 | 0 | 2021-04-19T16:37:30.117000-04:00 | |
| 2605951 | MEHLMAN CONSULTING, INC. 2b5ea278-8ae5-4753-a541-dede1cadfa42 | Q1 | MEHLMAN CONSULTING, INC. | 284950 | AMNEAL | 2021 | first_quarter | PHA | Monitoring legislative and regulatory efforts related to domestic supply chains of generic drugs. | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 60000 | 0 | 0 | 2021-04-19T17:13:19.467000-04:00 | |
| 2606005 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 30546d6e-a17f-4576-9750-18caebae1a77 | Q1 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 27478 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 2021 | first_quarter | PHA | S. 298 / H.R. 1829, the Pharmacy Benefit Manager Accountability Study Act of 2021; Draft legislation, Vaccine Injury Compensation Modernization; COVID vaccine distribution | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 360000 | 0 | 0 | 2021-04-19T17:19:31.493000-04:00 | |
| 2606080 | BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. 2bc7e58c-f11c-47be-873b-8db933b366ae | Q1 | BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. | 323876 | BLUE CROSS AND BLUE SHIELD OF KANSAS INC | 2021 | first_quarter | PHA | COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Vaccine Rollout | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 5000 | 0 | 0 | 2021-04-19T17:25:45.263000-04:00 | |
| 2606588 | THE MATHIS HARPLE GROUP 423ff54d-3ec1-4742-aebe-222ad776abc7 | Q1 | THE MATHIS HARPLE GROUP | 322911 | PILMA | 2021 | first_quarter | PHA | Price Controls, Intellectual Property Rights | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2021-04-19T18:20:39.403000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);